Narrative review synthesizes disease mechanisms of thyroid-associated orbitopathy in affected patients, suggesting existing evidence can guide rational targeted therapies.
A to understand the pathogenesis of thyroid-associated orbitopathy (TAO) have failed, in part because of confounding features associated with its variable clinical presentation. In the absence of a more complete insight into disease mechanisms, no specific and effective therapy can be developed. It is our view that much of the information necessary to unravel the complexities of TAO and therefore formulate rational therapy has already been gathered.
No takes yet. Share an insight, caveat, or question.
Michael Kazim (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: